IMA Q2 2024 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$67M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$400,000

Operating Income

-$16M

Net Income

-$14M

EPS (Diluted)

$-0.28

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$157M

Total Liabilities

$15M

Stockholders' Equity

$143M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$2M	-100.0%
Gross Profit	-$400,000	-$12M	+96.7%
Operating Income	-$16M	-$18M	+14.4%
Net Income	-$14M	-$17M	+19.8%